Mika Kontro

Mika Kontro, MD, PhD is an Adjunct Professor and Senior Researcher at the University of Helsinki's Institute for Molecular Medicine Finland (FIMM) and Clinicum HUS Comprehensive Cancer Center. His work bridges clinical hematology and molecular oncology, focusing on individualized therapies for acute leukemias.

• Academic Rank: Adjunct Professor
• Institution: University of Helsinki
• Key Roles: Group Leader at FIMM, Consultant in Clinical Hematology

Research Interests: Kontro specializes in precision medicine for hematological malignancies, particularly Acute Myeloid Leukemia (AML). His work emphasizes:

• Ex-vivo drug sensitivity testing for treatment personalization
• Development of digital twins for AML (project AMLDT)
• Combination therapies with bexmarilimab and azacitidine
• Clinical trial leadership (VenEx trial)

Scientific Contributions: Over 65 publications and multiple high-profile trials, including:

• Machine learning strategies for drug combinations
• Capillary sampling techniques for drug monitoring
• HLA-DR modulation in myeloid malignancies

Awards & Grants:

• K. Albin Johannson Cancer Research Fellow
• Sigrid Jusélius Foundation grant (€54,200)
• Cancer Foundation Finland grant (€50,000)